Company intelligence / Profile preview

CrossLink Life Sciences

Norcross, Georgia, USAcrosslinklifesciences.com ↗

Ownership: Private
Employees: ~385
Development stage: Commercial

Overview

CrossLink Life Sciences is the largest private orthopaedic and spine device distributorship in the United States. It is Stryker Orthopaedics’ largest U.S. distributor and provides a wide range of orthopaedic and spinal implants as well as related surgical products to healthcare providers nationwide. The company does not develop drugs or biologics but partners with leading medical device manufacturers to distribute their products.

Therapeutic areas: OtherRheumatologyNeurology
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

1 asset

bupivacaine + meloxicam

Commercial

Indications: Post-operative pain

Partnerships

Stryker Orthopaedics – largest U.S. distributor for Stryker’s orthopaedic and spine products.Other partnerships with major medical device innovators are referenced but not named specifically.

Beyond the preview

Go deeper on CrossLink Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CrossLink Life Sciences.

Explore the full profile